{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T07:56:22Z","timestamp":1764402982630,"version":"build-2065373602"},"reference-count":44,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100013238","name":"Mahidol University Faculty of Medicine Siriraj Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013238","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.vaccine.2020.01.074","type":"journal-article","created":{"date-parts":[[2020,2,15]],"date-time":"2020-02-15T22:44:18Z","timestamp":1581806658000},"page":"2725-2733","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Seroprevalence of Bordetella pertussis antibodies and anti-pertussis antibody response after a single dose of reduced-antigen combined diphtheria, tetanus, and acellular pertussis vaccine (Tdap) in pregnant Thai women"],"prefix":"10.1016","volume":"38","author":[{"given":"Nalat","family":"Sompagdee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0529-2930","authenticated-orcid":false,"given":"Sanitra","family":"Anuwutnavin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wanatpreeya","family":"Phongsamart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sansnee","family":"Senawong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pinklow","family":"Umrod","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amporn","family":"Robkhonburi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.vaccine.2020.01.074_b0005","doi-asserted-by":"crossref","first-page":"348","DOI":"10.3201\/eid0604.000404","article-title":"Reemergence of pertussis in the highly vaccinated population of the Netherlands: observations on surveillance data","volume":"6","author":"de Melker","year":"2000","journal-title":"Emerg Infect Dis."},{"issue":"6","key":"10.1016\/j.vaccine.2020.01.074_b0010","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1086\/514792","article-title":"Epidemiological features of pertussis in hospitalized patients in Canada, 1991\u20131997: report of the Immunization Monitoring Program-Active (IMPACT)","volume":"28","author":"Halperin","year":"1999","journal-title":"Clin Infect Dis."},{"issue":"2","key":"10.1016\/j.vaccine.2020.01.074_b0015","first-page":"128","article-title":"Seroprevalence of Bordetella pertussis antibody in pregnant women in Iran","volume":"14","author":"Hashemi","year":"2014","journal-title":"J Res Health Sci."},{"key":"10.1016\/j.vaccine.2020.01.074_b0020","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12879-016-1357-x","article-title":"Adult pertussis is unrecognized public health problem in Thailand","volume":"16","author":"Siriyakorn","year":"2016","journal-title":"BMC Infect Dis."},{"key":"10.1016\/j.vaccine.2020.01.074_b0025","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.3389\/fimmu.2019.01344","article-title":"Pertussis Prevention: Reasons for Resurgence, and Differences in the Current Acellular Pertussis Vaccines","volume":"10","author":"Esposito","year":"2019","journal-title":"Front Immunol."},{"issue":"3","key":"10.1016\/j.vaccine.2020.01.074_b0030","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1093\/clinids\/22.3.503","article-title":"Risk factors for pertussis in young infants during an outbreak in Chicago in 1993","volume":"22","author":"Izurieta","year":"1996","journal-title":"Clin Infect Dis."},{"issue":"6","key":"10.1016\/j.vaccine.2020.01.074_b0035","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1086\/514776","article-title":"Changing epidemiology of pertussis in the United States: increasing reported incidence among adolescents and adults, 1990\u20131996","volume":"28","author":"Guris","year":"1999","journal-title":"Clin Infect Dis."},{"issue":"4","key":"10.1016\/j.vaccine.2020.01.074_b0040","first-page":"73","article-title":"Pertussis-United States, 1997\u20132000","volume":"51","author":"Centers for Disease Control and Prevention","year":"2002","journal-title":"MMWR Morb Mortal Wkly Rep."},{"issue":"5","key":"10.1016\/j.vaccine.2020.01.074_b0045","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1067\/S0022-3476(03)00365-2","article-title":"Predictors of death in infants hospitalized with pertussis: a case-control study of 16 pertussis deaths in Canada","volume":"143","author":"Mikelova","year":"2003","journal-title":"J Pediatr."},{"issue":"5 Suppl","key":"10.1016\/j.vaccine.2020.01.074_b0050","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.1097\/01.inf.0000160915.93979.8f","article-title":"Role of maternal pertussis antibodies in infants","volume":"24","author":"Van Rie","year":"2005","journal-title":"Pediatr Infect Dis J."},{"issue":"2","key":"10.1016\/j.vaccine.2020.01.074_b0055","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1086\/421033","article-title":"Prevalence of pertussis antibodies in maternal delivery, cord, and infant serum","volume":"190","author":"Healy","year":"2004","journal-title":"J Infect Dis."},{"issue":"11","key":"10.1016\/j.vaccine.2020.01.074_b0060","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1097\/01.inf.0000145263.37198.2b","article-title":"Infant pertussis: who was the source?","volume":"23","author":"Bisgard","year":"2004","journal-title":"Pediatr Infect Dis J."},{"issue":"2","key":"10.1016\/j.vaccine.2020.01.074_b0065","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1080\/10647440500068289","article-title":"Seroprevalence of Bordetella pertussis antibodies in mothers and their newborn infants","volume":"13","author":"Gonik","year":"2005","journal-title":"Infect Dis Obstet Gynecol."},{"issue":"4","key":"10.1016\/j.vaccine.2020.01.074_b0070","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1093\/cid\/cis923","article-title":"Importance of timing of maternal combined tetanus, diphtheria, and acellular pertussis (Tdap) immunization and protection of young infants","volume":"56","author":"Healy","year":"2013","journal-title":"Clin Infect Dis."},{"issue":"20","key":"10.1016\/j.vaccine.2020.01.074_b0075","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1016\/S0264-410X(98)00227-8","article-title":"Levels of anti-pertussis antibodies related to protection after household exposure to Bordetella pertussis","volume":"16","author":"Storsaeter","year":"1998","journal-title":"Vaccine."},{"issue":"40","key":"10.1016\/j.vaccine.2020.01.074_b0080","doi-asserted-by":"crossref","first-page":"885","DOI":"10.15585\/mmwr.mm6840e1","article-title":"Vital Signs: Burden and Prevention of Influenza and Pertussis Among Pregnant Women and Infants - United States","volume":"68","author":"Lindley","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep."},{"issue":"12","key":"10.1016\/j.vaccine.2020.01.074_b0085","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1093\/cid\/cix724","article-title":"Impact of the US Maternal Tetanus, Diphtheria, and Acellular Pertussis Vaccination Program on Preventing Pertussis in Infants <2 Months of Age: A Case-Control Evaluation","volume":"65","author":"Skoff","year":"2017","journal-title":"Clin Infect Dis."},{"issue":"7","key":"10.1016\/j.vaccine.2020.01.074_b0090","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1093\/cid\/ciw027","article-title":"Maternal Immunization Earlier in Pregnancy Maximizes Antibody Transfer and Expected Infant Seropositivity Against Pertussis","volume":"62","author":"Eberhardt","year":"2016","journal-title":"Clin Infect Dis."},{"issue":"8","key":"10.1016\/j.vaccine.2020.01.074_b0095","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1093\/cid\/cix046","article-title":"Pertussis Antibody Transfer to Preterm Neonates After Second- Versus Third-Trimester Maternal Immunization","volume":"64","author":"Eberhardt","year":"2017","journal-title":"Clin Infect Dis."},{"issue":"10","key":"10.1016\/j.vaccine.2020.01.074_b0100","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1099\/jmm.0.000829","article-title":"Review of vaccination in pregnancy to prevent pertussis in early infancy","volume":"67","author":"Campbell","year":"2018","journal-title":"J Med Microbiol."},{"issue":"suppl 4","key":"10.1016\/j.vaccine.2020.01.074_b0105","doi-asserted-by":"crossref","first-page":"S236","DOI":"10.1093\/cid\/ciw559","article-title":"Sustained Effectiveness of the Maternal Pertussis Immunization Program in England 3 Years Following Introduction","volume":"63","author":"Amirthalingam","year":"2016","journal-title":"Clin Infect Dis."},{"issue":"3","key":"10.1016\/j.vaccine.2020.01.074_b0110","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/cid\/ciu821","article-title":"A case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and Wales, 2012\u20132013","volume":"60","author":"Dabrera","year":"2015","journal-title":"Clin Infect Dis."},{"issue":"9953","key":"10.1016\/j.vaccine.2020.01.074_b0115","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/S0140-6736(14)60686-3","article-title":"Effectiveness of maternal pertussis vaccination in England: an observational study","volume":"384","author":"Amirthalingam","year":"2014","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.vaccine.2020.01.074_b0120","doi-asserted-by":"crossref","first-page":"e153","DOI":"10.1097\/AOG.0000000000002301","article-title":"Update on Immunization and Pregnancy: Tetanus, Diphtheria, and Pertussis Vaccination","volume":"130","author":"Committee Opinion No. 718","year":"2017","journal-title":"Obstet Gynecol."},{"issue":"7","key":"10.1016\/j.vaccine.2020.01.074_b0125","first-page":"131","article-title":"Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) in pregnant women\u2013Advisory Committee on Immunization Practices (ACIP), 2012","volume":"62","author":"Centers for Disease Control and Prevention","year":"2013","journal-title":"MMWR Morb Mortal Wkly Rep."},{"issue":"5","key":"10.1016\/j.vaccine.2020.01.074_b0130","first-page":"1132","article-title":"Diphtheria outbreak in Thailand, 2012; seroprevalence of diphtheria antibodies among Thai adults and its implications for immunization programs","volume":"45","author":"Wanlapakorn","year":"2014","journal-title":"Southeast Asian J Trop Med Public Health."},{"issue":"7","key":"10.1016\/j.vaccine.2020.01.074_b0135","doi-asserted-by":"crossref","DOI":"10.1093\/femspd\/ftv050","article-title":"Seroprevalence studies of pertussis: what have we learned from different immunized populations","volume":"73","author":"Barkoff","year":"2015","journal-title":"Pathog Dis."},{"issue":"2","key":"10.1016\/j.vaccine.2020.01.074_b0140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0148338","article-title":"Seroprevalence of Antibodies to Pertussis Toxin among Different Age Groups in Thailand after 37 Years of Universal Whole-Cell Pertussis Vaccination","volume":"11","author":"Wanlapakorn","year":"2016","journal-title":"PLoS ONE"},{"issue":"3","key":"10.1016\/j.vaccine.2020.01.074_b0145","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/QCO.0000000000000372","article-title":"Placental transfer of antibody and its relationship to vaccination in pregnancy","volume":"30","author":"Calvert","year":"2017","journal-title":"Curr Opin Infect Dis."},{"issue":"3","key":"10.1016\/j.vaccine.2020.01.074_b0150","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s10096-010-1104-y","article-title":"What to do and what not to do in serological diagnosis of pertussis: recommendations from EU reference laboratories","volume":"30","author":"Guiso","year":"2011","journal-title":"Eur J Clin Microbiol Infect Dis."},{"issue":"3","key":"10.1016\/j.vaccine.2020.01.074_b0155","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1128\/CVI.00372-08","article-title":"Characterization of reference materials for human antiserum to pertussis antigens by an international collaborative study","volume":"16","author":"Xing","year":"2009","journal-title":"Clin Vaccine Immunol."},{"issue":"4","key":"10.1016\/j.vaccine.2020.01.074_b0160","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1086\/603555","article-title":"Kinetics of pertussis immune responses to tetanus-diphtheria-acellular pertussis vaccine in health care personnel: implications for outbreak control","volume":"49","author":"Kirkland","year":"2009","journal-title":"Clin Infect Dis."},{"issue":"3","key":"10.1016\/j.vaccine.2020.01.074_b0165","first-page":"447","article-title":"Pertussis in Thai adult and pediatric patients presenting with prolonged acute cough","volume":"49","author":"Chinthanate","year":"2018","journal-title":"Southeast Asian J Trop Med Public Health."},{"key":"10.1016\/j.vaccine.2020.01.074_b0170","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.4043","article-title":"Antibodies to Bordetella pertussis antigens in maternal and cord blood pairs: a Thai cohort study","volume":"5","author":"Wanlapakorn","year":"2017","journal-title":"PeerJ"},{"issue":"17","key":"10.1016\/j.vaccine.2020.01.074_b0175","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1001\/jama.2014.3633","article-title":"Safety and immunogenicity of tetanus diphtheria and acellular pertussis (Tdap) immunization during pregnancy in mothers and infants: a randomized clinical trial","volume":"311","author":"Munoz","year":"2014","journal-title":"JAMA"},{"issue":"24","key":"10.1016\/j.vaccine.2020.01.074_b0180","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.1001\/jama.293.24.3003","article-title":"Combined tetanus, diphtheria, and 5-component pertussis vaccine for use in adolescents and adults","volume":"293","author":"Pichichero","year":"2005","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.vaccine.2020.01.074_b0185","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.vaccine.2015.10.098","article-title":"Pertussis vaccination during pregnancy in Vietnam: results of a randomized controlled trial Pertussis vaccination during pregnancy","volume":"34","author":"Hoang","year":"2016","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2020.01.074_b0190","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1093\/cid\/ciy244","article-title":"A Randomized Controlled Trial of the Safety and Immunogenicity of Tetanus, Diphtheria, and Acellular Pertussis Vaccine Immunization During Pregnancy and Subsequent Infant Immune Response","volume":"67","author":"Halperin","year":"2018","journal-title":"Clin Infect Dis."},{"issue":"34","key":"10.1016\/j.vaccine.2020.01.074_b0195","doi-asserted-by":"crossref","first-page":"5173","DOI":"10.1016\/j.vaccine.2018.07.011","article-title":"Pertussis Immunisation in Pregnancy Safety (PIPS) Study: a retrospective cohort study of safety outcomes in pregnant women vaccinated with Tdap vaccine","volume":"36","author":"Griffin","year":"2018","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2020.01.074_b0200","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/j.vaccine.2018.01.059","article-title":"Assessing the reactogenicity of Tdap vaccine administered during pregnancy and antibodies to Bordetella pertussis antigens in maternal and cord sera of Thai women","volume":"36","author":"Wanlapakorn","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.01.074_b0205","doi-asserted-by":"crossref","unstructured":"Zheteyeva YA, Moro PL, Tepper NK, Rasmussen SA, Barash FE, Revzina NV, et al. Adverse event reports after tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccines in pregnant women. Am J Obstet Gynecol. 2012;207(1):59 e1-7.","DOI":"10.1016\/j.ajog.2012.05.006"},{"issue":"14","key":"10.1016\/j.vaccine.2020.01.074_b0210","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1001\/jama.2018.14298","article-title":"Association Between Third-Trimester Tdap Immunization and Neonatal Pertussis Antibody Concentration","volume":"320","author":"Healy","year":"2018","journal-title":"JAMA"},{"issue":"44","key":"10.1016\/j.vaccine.2020.01.074_b0215","doi-asserted-by":"crossref","first-page":"5787","DOI":"10.1016\/j.vaccine.2014.08.038","article-title":"The effect of timing of maternal tetanus, diphtheria, and acellular pertussis (Tdap) immunization during pregnancy on newborn pertussis antibody levels - a prospective study","volume":"32","author":"Abu Raya","year":"2014","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2020.01.074_b0220","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1086\/605575","article-title":"Seroprevalence of Bordetella pertussis infection during pregnancy measured by IgG antibodies against pertussis toxin","volume":"49","author":"Nooitgedagt","year":"2009","journal-title":"Clin Infect Dis."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X2030116X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X2030116X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:40:15Z","timestamp":1759401615000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X2030116X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":44,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S0264410X2030116X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.01.074","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Seroprevalence of Bordetella pertussis antibodies and anti-pertussis antibody response after a single dose of reduced-antigen combined diphtheria, tetanus, and acellular pertussis vaccine (Tdap) in pregnant Thai women","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.01.074","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}